Study Finds Bortezomib to Be Promising for Treatment of Rheumatoid Arthritis
Links shared publicly online about this topic
Study finds bortezomib to be promising treatment for rheumatoid arthritis
physorg.com — “A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model ...” View full resource at physorg.com
Most Recently Shared on November 3, 2010 at 4:26 pm By:
Study finds bortezomib to be promising treatment for rheumatoid arthritis http://bit.ly/dld92C
Bortezomib Promising Treatment for Rheumatoid Arthritis
disabled-world.com — “Study suggests biologic drug bortezomib (Velcade) may represent a promising treatment for rheumatoid arthritis” View full resource at disabled-world.com
Most Recently Shared on November 4, 2010 at 1:39 pm By:
Disabled World Health Advocate and Health News
Bortezomib Promising Treatment for Rheumatoid Arthritis http://ff.im/-t9rfq
Is Rheumatoid Arthritis Prevention on the Horizon? - New Study Shows Promising Results
spineuniverse.com — “Researchers created a treatment to potentially prevent or reverse rheumatoid arthritis (RA) by imitating a molecule that causes attacking immune cells to self-destruct. The findings may help develop a new class of rheumatoid arthritis medications.” View full resource at spineuniverse.com
Most Recently Shared on July 14, 2011 at 11:27 pm By:
Is Rheumatoid Arthritis Prevention on the Horizon? http://dlvr.it/bCjl0
Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise in the Treatment of Active Rheumatoid Arthritis - Health News - redOrbit
redorbit.com — “LONDON, May 25, 2011 /PRNewswire/ -- Results from a Phase 2 multicenter, randomized, double-blind, proof-of-concept and dose-finding study showed that treatment with sirukumab (CNTO 136) improved signs and symptoms of rheumatoid arthritis (RA) in patients with active disease despite treatment with methotrexate (MTX).” View full resource at redorbit.com
Most Recently Shared on May 25, 2011 at 4:03 pm By:
Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise in the Treatment of Active Rheumatoid Art... http://bit.ly/mcrr2L
Arthritis drug could help beat melanoma skin cancer, study finds
sciencedaily.com — “A breakthrough discovery promises an effective new treatment for one of the deadliest forms of cancer. Researchers found that leflunomide -- a drug commonly used to treat rheumatoid arthritis -- also inhibits the growth of malignant melanoma.” View full resource at sciencedaily.com
Most Recently Shared on March 24, 2011 at 12:10 am By:
Arthritis drug could help beat melanoma skin cancer, study finds: A breakthrough discovery promises an effective... http://bit.ly/gnLp5g
Arthritis drug could help beat melanoma skin cancer, study finds
sciencedaily.com — “A breakthrough discovery promises an effective new treatment for one of the deadliest forms of cancer. Researchers found that leflunomide -- a drug commonly used to treat rheumatoid arthritis -- also inhibits the growth of malignant melanoma.” View full resource at sciencedaily.com
Most Recently Shared on March 24, 2011 at 7:50 am By:
Arthritis drug could help beat melanoma skin cancer, study finds: A breakthrough discovery promises an effective... http://bit.ly/i4selx
Proteasome inhibitor reduces inflammation and promotes bone healing in arthritis models
sciencedaily.com — “A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing.” View full resource at sciencedaily.com
Most Recently Shared on November 3, 2010 at 1:12 pm By:
Proteasome inhibitor reduces inflammation and promotes bone healing in arthritis models: A new study by Greek rese... http://bit.ly/bzFruY
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
-
SpineUniverse
Reporting on the health of your back, spine, and neck - www.spineuniverse.com
Advertisement
